Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 29, 2024 11:30 ET | Source: Research and Markets

Alzheimer's Drugs Market Report 2024, with Profiles of 10+ Companies Including AbbVie, Biogen, Daiichi Sankyo, Eisai, Eli Lilly, H. Lundbeck, Lupin, Merck, Novartis, Pfizer, Teva Pharmaceutical & More

Dublin, Oct. 29, 2024 (GLOBE NEWSWIRE) -- The "Alzheimer's Drugs - A Global Market Overview" report has been added to ResearchAndMarkets.com's offering.The global market for Alzheimer's Drugs is...
January 25, 2024 09:02 ET | Source: Research and Markets

Japan Alzheimer's Disease Market Forecast to 2032 Demonstrates Increasing Diagnosed Prevalence and Growth Following Novel Treatment Approaches

Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Japan Alzheimer's Disease - Market Insight, Epidemiology and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. The...
August 23, 2023 05:53 ET | Source: Research and Markets

Global Alzheimer's Disease Industry Forecast, 2032: Breakthrough Therapies and Market Trends

Dublin, Aug. 23, 2023 (GLOBE NEWSWIRE) -- The "Global Alzheimer's Disease Market 2023-2032" report has been added to ResearchAndMarkets.com's offering. Alzheimer's disease, a progressive...
February 17, 2023 10:38 ET | Source: Research and Markets

Alzheimer's Disease Diagnostics and Therapeutics Global Market Report 2023: Increasing Use of Biomarkers for Diagnosis Drives Growth

Dublin, Feb. 17, 2023 (GLOBE NEWSWIRE) -- The "Alzheimer's disease diagnostics and therapeutics Market, by Product, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030"...
February 15, 2023 06:58 ET | Source: Research and Markets

World Alzheimer's Disease Therapeutics Analysis Report 2022: A $4.26 Billion Market by 2028 - Market Insights, Epidemiology and Pipeline Assessments

Dublin, Feb. 15, 2023 (GLOBE NEWSWIRE) -- The "Alzheimer's Disease Therapeutics (2022 Edition) - Market Insight, Epidemiology and Pipeline Assessment (By Molecule Type, By Route of Administration,...
February 08, 2023 10:23 ET | Source: Research and Markets

Global Alzheimer's Disease Therapeutics Market Research Report 2023: Forecasts, Epidemiology & Pipeline Analysis 2022-2028

Dublin, Feb. 08, 2023 (GLOBE NEWSWIRE) -- The "Alzheimer's Disease Therapeutics Market Forecast - Epidemiology & Pipeline Analysis 2023-2028" report has been added to ResearchAndMarkets.com's...
August 30, 2022 06:08 ET | Source: Research and Markets

Global Alzheimer's Therapeutics Market Analysis Report 2022: A Potential $15.6 Billion Market by 2030

Dublin, Aug. 30, 2022 (GLOBE NEWSWIRE) -- The "Global Alzheimer's Therapeutics Market Size, Share & Trends Analysis Report by Product (Cholinesterase Inhibitors, Pipeline Drugs), by End Use, by...
February 15, 2022 07:08 ET | Source: Research and Markets

Global Alzheimer Drugs Market Report 2022: A Market Valued at $6,537.0 Million in 2021 - Forecast to 2027

Dublin, Feb. 15, 2022 (GLOBE NEWSWIRE) -- The "Global Alzheimer Drugs Market (2022 Edition) - Analysis By Drug Class (Cholinergic, Memantine, Combined Drugs, Others), Distribution Channel, By...
February 04, 2022 10:47 ET | Source: National Down Syndrome Society

National Down Syndrome Organizations Launch Joint Effort To Change CMS Proposal Concerning Coverage For New Class Of Alzheimer’s Treatments

Atlanta, GA., Bismarck, ND., Burlington, MA., Denver, CO., Hoffman Estates, IL, NY, NY, Rockport, ME, Feb. 04, 2022 (GLOBE NEWSWIRE) -- Down Syndrome Affiliates in Action (DSAIA), GiGi’s Playhouse...
November 24, 2021 02:48 ET | Source: Research and Markets

Global Alzheimer's Disease Market Report 2021-2030: Current Landscape of the Marketed, Clinical and Preclinical Molecules Available/Being Developed for Treatment

Dublin, Nov. 24, 2021 (GLOBE NEWSWIRE) -- The "Alzheimer's Disease Market (2nd edition) by Type of Treatment (Symptomatic and Disease Modifying), Symptomatic Indications (Dementia, Insomnia and...

Next Page keyboard_arrow_right